Concepedia
5
Publications
106
Citations
H-Index
2018
Active since
Affiliations
Fate Therapeutics (United States)(Current)
Max Delbrück Center
John Reiser is an author at Fate Therapeutics (United States) specializing in autoimmunity, cell biology, and medicine.
Top concepts
MedicineImmunologyAutoimmunityCell BiologyInflammationImmune Regulation
Publications per year
2018–2024
FT576: Multi-Specific Off-the-Shelf CAR-NK Cell Therapy Engineered for Enhanced Persistence, Avoidance of Self-Fratricide and Optimized Mab Combination Therapy to Prevent Antigenic Escape and Elicit a Deep and Durable Response in Multiple Myeloma
Jode Goodridge, Ryan Bjordahl, Sajid Mahmood et al. · Blood · 2020 · 40 citations
FT555: Off-the-Shelf CAR-NK Cell Therapy Co-Targeting GPRC5D and CD38 for the Treatment of Multiple Myeloma
John Reiser, Szeman Ruby Chan, Ketan Mathavan et al. · Blood · 2022 · 23 citations
Eomesodermin driven IL-10 production in effector CD8+ T cells promotes a memory phenotype
John Reiser, Kavitha Sadashivaiah, Aki Furusawa et al. · Cellular Immunology · 2018 · 17 citations
Inflammation, Immune Regulation, Immunology +7
CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma
Michael W. Moles, Henry Erdlei, Lutz Menzel et al. · Frontiers in Immunology · 2024 · 16 citations · Full text
Dual Chimeric Antigen Receptor Approach Combining Novel Tumor Targeting Strategies Circumvents Antigen Escape in Multiple Myeloma
John Reiser, Ketan Mathavan, Sajid Mahmood et al. · Blood · 2021 · 10 citations
Rows per page
1–5 of 5